Search research articles
Contact Us
Filters
Showing results (31-40 of 66) with videos related to
Page
of 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2023
Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up
Sia V Lindskrog, Karin Birkenkamp-Demtröder, Iver Nordentoft, et al.
European Urology
|
July 27, 2023
Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma
Thomas Powles, Zoe June Assaf, Viraj Degaonkar, et al.
Molecular Oncology
|
December 1, 2023
Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors
Ekaterina Kalashnikova, Vasily N Aushev, Allyson Koyen Malashevich, et al.
Nature Medicine
|
January 16, 2023
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
Daisuke Kotani, Eiji Oki, Yoshiaki Nakamura, et al.
Cancer Science
|
November 28, 2021
DENEB: Development of new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy
Masaaki Miyo, Takeshi Kato, Yoshiaki Nakamura, et al.
NPJ Breast Cancer
|
March 26, 2021
Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk
Mark Jesus M Magbanua, Wen Li, Denise M Wolf, et al.
JCO Precision Oncology
|
December 8, 2022
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers
Brandon M Huffman, Vasily N Aushev, Griffin L Budde, et al.
Frontiers in Oncology
|
August 21, 2023
Molecular residual disease detection in resected, muscle-invasive urothelial cancer with a tissue-based comprehensive genomic profiling-informed personalized monitoring assay
Thomas Powles, Amanda Young, Halla Nimeiri, et al.
JCO Precision Oncology
|
March 9, 2022
Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors
Pashtoon M Kasi, Gordon Fehringer, Hiroya Taniguchi, et al.
JAMA Oncology
|
December 4, 2025
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial
George Q Zhang, Jeffrey A Meyerhardt, Qian Shi, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 66) with videos related to
Sort By:
Page
of 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2023
Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up
Sia V Lindskrog, Karin Birkenkamp-Demtröder, Iver Nordentoft, et al.
European Urology
|
July 27, 2023
Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma
Thomas Powles, Zoe June Assaf, Viraj Degaonkar, et al.
Molecular Oncology
|
December 1, 2023
Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors
Ekaterina Kalashnikova, Vasily N Aushev, Allyson Koyen Malashevich, et al.
Nature Medicine
|
January 16, 2023
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
Daisuke Kotani, Eiji Oki, Yoshiaki Nakamura, et al.
Cancer Science
|
November 28, 2021
DENEB: Development of new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy
Masaaki Miyo, Takeshi Kato, Yoshiaki Nakamura, et al.
NPJ Breast Cancer
|
March 26, 2021
Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk
Mark Jesus M Magbanua, Wen Li, Denise M Wolf, et al.
JCO Precision Oncology
|
December 8, 2022
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers
Brandon M Huffman, Vasily N Aushev, Griffin L Budde, et al.
Frontiers in Oncology
|
August 21, 2023
Molecular residual disease detection in resected, muscle-invasive urothelial cancer with a tissue-based comprehensive genomic profiling-informed personalized monitoring assay
Thomas Powles, Amanda Young, Halla Nimeiri, et al.
JCO Precision Oncology
|
March 9, 2022
Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors
Pashtoon M Kasi, Gordon Fehringer, Hiroya Taniguchi, et al.
JAMA Oncology
|
December 4, 2025
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial
George Q Zhang, Jeffrey A Meyerhardt, Qian Shi, et al.
Page
of 7